U.S. Leisure Stock News

SoFi Technologies rose 8% to $16.47 after the earnings were released, a sharp move for a stock that had been roughly flat over the past week and down about 11% over the past month. The market is reacting to one thing above all else. SoFi reported roughly $1.2 billion in Q2 revenue with about $160 million in net income, and management is emphasizing that performance. In the short term, this is a fintech stock that has reported scale revenue and profit. Over the longer term, the key question is...

Microsoft stock ripped higher today, jumping about 15% to roughly US$451 after a single quarter forced investors to rethink what they are willing to pay for the company. The move caps a strong run over the past month, and the real story sits in the earnings power that drove this repricing. Full year revenue reached about US$332b with operating income north of US$155b, and trailing earnings now put Microsoft on a P/E of roughly 25x. The market reaction is loud. The question for you is how long...

Verisk Analytics stock just gave up 6% in a single session even though the earnings story looked far calmer than the price chart. Coming into the release, the stock had quietly built a solid short term run, with gains over the past month and quarter. This made today’s drop feel like a sentiment reset rather than a sudden fundamental shock. The main focus was on margins and valuation. Trailing net margin of 28.2% is lower than a year ago, while the P/E multiple still sits above both peer and...

Teva Pharmaceutical Industries stock inched up about 2% to US$35.41 into the earnings reaction, which suggests a calm headline move for what is actually a noisy quarter. The real story is a sharp quarterly earnings swing into a reported net loss of US$576 million and basic earnings per share of US$0.49 loss, driven largely by acquisition related research and development charges. Behind that profit squeeze, revenue of about US$4.1b kept the top line broadly steady for a large global drug...

VF Corporation stock barely flinched after earnings, slipping about 1% to US$14.96. For a company that just posted another quarterly loss and is still working through brand and balance sheet repair, that is a surprisingly calm response. The headline is simple: Revenue for Q1 2027 held around US$1.7b while the company reported a basic loss per share of about US$0.25. The real emotional driver is elsewhere. Investors are weighing that loss against improving trailing earnings and a debt load...

The market clipped Cognizant Technology Solutions by about 4% today, yet the earnings story is more complex than that price move suggests. You are looking at a stock that has quietly outperformed over the past month while trading on a trailing P/E below both peer and broader United States information technology industry averages. The headline this quarter is margin and profit pressure. Net profit margin over the last 12 months sat at 10.3%, down from 11.9% a year earlier, even as Q2 adjusted...

Johnson Controls International stock jumped 3.2% to US$143.88 into the close, even though the past month has been slightly soft for holders. The spark was a clean earnings beat in a core industrial business that investors watch closely for cash and margin quality. The headline this quarter is margin power in a capital intensive sector. Adjusted earnings per share reached US$1.42 with adjusted earnings before interest and tax margin at 17%, and orders and backlog both sitting at record levels...

CBIZ walked into this earnings print with the stock quietly grinding higher over the past quarter, then tacked on another 0.6% today. That calm price reaction sits against a quarter where headline earnings power looked softer on the surface, with basic earnings per share of about US$0.31 on US$682.2m of revenue. The real story for CBIZ now sits in the tension between that single quarter and a trailing 12 month earnings profile that has been growing and carries a premium P/E to its...

Wingstop stock came into this report already under pressure, down over 23% across the past month, and the selloff deepened today with the shares slipping another 3.7% to about US$134. Yet the headline from the quarter is not a collapse in profitability. Net income reached US$31.3m, with diluted earnings per share at US$1.15, and adjusted EBITDA grew at a double digit rate. The real flashpoint is on the top line. Domestic same store sales declined 7.5% even as system wide sales grew through...

Hawkins stock just handed short term traders a headache. The shares closed about 7% lower, extending a three month slide of more than 20%. Yet the latest quarter delivered what longer term holders usually want in a specialty chemicals business. Revenue reached about US$315.7m and basic earnings per share came in around US$1.36, both solidly ahead of the recent run rate. The tension is clear. The market is punishing a richer P/E and softer margins, while the income statement still points to a...

Waystar Holding stock just absorbed a 14.6% hit in a single session, even though the earnings story centered on expanding profitability rather than a crack in the business model. Coming into the print, shares had been roughly flat over three months. This framed today’s selloff as a sharp reset, not the end of a long slide. The headline from the quarter was margin power. Adjusted EBITDA reached US$137m on US$320m of revenue, with a 43% margin that sat ahead of expectations and in line with...

Arm Holdings just added $16.65 a share in a single session, a 7.4% jump that stands out against a stock that was down about 31.9% over the past month. The spark was a Q1 FY2027 print that leaned into what matters most for this story right now: profit quality. Revenue came in at US$1.29b with net income of US$270m, and management held non GAAP operating margin near the low 40% range. For a stock already debated on valuation, a cash rich, high margin quarter is what moved the needle. Love the...

Carvana just gave investors a sentiment whiplash. The stock closed at US$66.32 before the earnings release and then fell about 7% to US$61.44, even as the company reported record quarterly revenue of US$7.376b and a trailing net profit margin of 6.3%. The market is cooling on the story at the very moment the financials show the used car retailer solidly in the black. The real fault line is valuation. Carvana trades on a P/E of 28.2x against a peer group closer to 20x, while the share price...

Moelis stock jumped about 4.8% to US$68.35 into the close, which indicates that investors liked what they saw. The real story is not a one day pop. It is that Moelis just reported record Q2 2026 revenue of about US$409 million with an adjusted pretax margin near 18.6% in a fee based advisory business where margins drive sentiment. The move in the share price aligns closely with that margin story. The compensation ratio stepped down to roughly 65.8%, which signals to the market that Moelis is...

Old Dominion Freight Line stock gave up 4.6% today, even though the latest quarter delivered exactly what long term holders usually want from a less than truckload carrier. Revenue reached US$1.55b while basic earnings per share came in at US$1.69, matching the company’s record. The real story sat in profitability, with management reporting an operating ratio of 70.1%, which is very lean for this industry. Short term traders focused on the price drop. Long term investors are more likely to...

Vertiv Holdings came into this print looking tired, with the stock down over 30% in the last three months, yet the market snapped back on the release, pushing the shares up about 2% on the day. The move reflects how hard it is to square a weak recent chart with the strength of the latest earnings story. Vertiv just posted around US$3.27b of Q2 revenue and roughly US$1.29 of basic earnings per share, while trailing P/E sits near 50.5x. For a premium priced data center infrastructure stock,...

Teladoc Health just gave shareholders a brutal reminder that cheap can always get cheaper. The stock closed at US$9.18 before the report and is now marked around US$6.58, a slide of more than 28% that wipes out the recent 7 day and 30 day bounce attempts. Yet the headline from the quarter is not a collapse in the core virtual care engine. The story is a pressure point in BetterHelp, where falling cash pay revenue and a thin margin are colliding with a long term bet on insurance based...

The market barely flinched on ArcBest’s Q2 release. The stock inched up about 0.4% despite a headline that, on paper, looks far more dramatic than that move suggests. ArcBest posted a Q2 net loss and negative basic earnings per share while still delivering higher revenue and stronger non GAAP operating income. This is a margin story more than a growth story. Freight investors are weighing a reported loss that reflects heavy restructuring and impairment charges against an improving operating...

The market barely flinched on Humana’s earnings, with the stock up just 0.3% around US$366. That muted move sits against a report defined by margin repair rather than headline growth. Quarterly basic earnings per share of US$5.78 and net income of US$694m came alongside a clear message. Management is leaning hard into restoring Medicare Advantage profitability after a year of thinner margins and a large one off loss in the trailing period. For investors, the real story is whether this slow...

United Natural Foods recently reported that its natural product sales grew more than 4% in fiscal 2026, while it rolled out new digital tools, refreshed private-label offerings, and continued heavy investment in modernizing its supply-chain operations. This combination of category growth and technology-driven efficiency initiatives underscores how UNFI is trying to reinforce its role as a key distributor for health-focused retailers and brands. Next, we’ll examine how UNFI’s renewed push...

Watsco came into this earnings print with the stock drifting lower for months and another 2.9% slide today, despite posting one of its seasonally strongest quarters. The market is leaning away from the long term HVAC distribution story just as the company reported US$2.1b in Q2 revenue and US$4.28 in basic earnings per share. The headline is not growth at any cost. Investors are focusing on margins. Gross margin landed at 27.5% and trailing net margin sits at 6.1%, both a step down from a...

New Oriental Education & Technology Group saw its stock slip 3.4% to US$56.58, even though the headline number pointed in the opposite emotional direction for many investors. Revenue in the latest quarter reached US$1,529.5m and non GAAP operating income came in at US$110m, which management framed as part of a broader profitability push. The tension today sits squarely between a premium P/E of 18.9x and a business still delivering earnings growth and higher net profit margins. The price fall...

Enterprise Products Partners has delivered a 146.4% total return over the past five years, yet the latest valuation checks send a more measured signal about how much upside might still be left in the current price of US$38.12. A 146.4% return over five years points to a stock that has already rewarded patient holders, which raises the bar for any new valuation upside. Future cash flow resilience from its midstream infrastructure can support current pricing, while any sustained pressure on...

In July 2026, Celcuity announced that its drug REVTORPYK (gedatolisib) received FDA approval and NCCN Category 1 preferred guideline status for use with fulvestrant, with or without palbociclib, in adults with HR+/HER2- locally advanced or metastatic breast cancer without a PIK3CA mutation after progression on endocrine therapy. A key differentiator is that REVTORPYK is the only FDA-approved therapy targeting all class I PI3K isoforms and both mTORC1 and mTORC2 complexes, supported by...